Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Schwerpunkte

Schwerpunkte Forschung

  • Tissue Engineering, Gentherapie mit Osteogenic Protein-1
  • Stammzelltherapie bei Kieferdefekten, Kollagenforschung, Isolierung und Klonierung hochwirksamer archaischer antimikrobieller Peptide. Die Projekte werden hochrangig gefördert
  • Auftragsforschung, Biomaterialien
  • Speziallabore für Tumordiagnostik
  • Speziallabore für Knochenbiologie
  • Periimplantitis
  • Versorgungsforschung

Kooperationen

ISOLATION OF MESENCHYMAL STEM CELLS FROM PERIPHERAL BLOOD

Privatdozent Dr. med. dent. Aydin Gülses, Staatliche Krankenhausvereinigung - Gesundheitsministerium der Republik Türkei

Associate Professor DDS PhD Aydin Gülses, Public Hospital Association - Ministry of Health of the Republic of Turkey

 

Responsible researchers:

Assoc Prof. Dr. Aydin Gülsesa, Prof rer. nat. Yahya Açil, Prof. Dr. Dr. Jörg Wiltfang

Study duration

12 months

Scientific/clinical background

Reconstructive management of craniomaxillofacial bone deficiencies remains still challenging. In the past, several techniques have been described for the isolation of mesenchymal stem cells (MCs) from various tissues/organs. Despite the presence of drawbacks and potential risks regarding the general anethesia and the invasive surgical intervention protocol, the use of bone aspirates collected from the iliac crest is still the most accepted method for optimizing bone volume in craniomaxillofacial reconstruction. 1In order to overcome the above mentioned disadvantages, current study aimed to the demonstrate a novel technique by using peripheral blood samples for isolation of MSCs and define its potential superiority over the previously described methods.

Material and methods

Peripheral blood samples taken from healthy individuals twice in a row will  be included in the study. They will be subdivided into two groups regarding the protocol used. In the study group, the samples will be used for direct isolation of the MSCs, whereas the other samples will be managed by the FICOLL protocol. After cell transplantation the viability of the cells and their proliferation capacities will be sustained. Following this, FACS analysis method will be used to isolate the MSCs. For this purpose, required surface antigens will be supplied by the Department of Immunology of Christian Albrechts University.

Potential influential observations

  • Comparison of the osteoblactic ,fibroblastic and chondrogenic differentiation capacities of MSCs obtained by peripheral blood samples with the MSCs harvested from the iliac bone marrow aspirates.
  • Evaluation of the biological properties of both MSCs (peripheral blood vs iliac bone marrow) via cultivation on titanium blocks and animal-derived bone graft materials .